Publication | Open Access

Gemcitabine plus sirolimus for relapsed and progressing osteosarcoma patients after standard chemotherapy: a multicenter, single-arm phase II trial of Spanish Group for Research on Sarcoma (GEIS)

Spanish GroupOsteosarcoma PatientsOncologyStandard ChemotherapyMetronomic TherapyPathologyCancer TreatmentMedicineRadiation OncologyCancer Research